Back to Search
ANJALI KAMAT, M.D.
M.D.
Internal Medicine Physician
NPI: 1578729471IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist Physician
Hospitalist
Code: 208M00000X
2010016629(MO)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2010016629(MO)
Education
OTHER
Class of 2002
Research & Publications (20)
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
PMID 19396818·Cancer·2009
8-other
Definition and management of patients with bladder cancer who fail BCG therapy.
PMID 19496718·Expert Rev Anticancer Ther·2009
6-review
Functional significance of VEGFR-2 on ovarian cancer cells.
PMID 19058181·Int J Cancer·2009
7-preclinical
Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk.
PMID 19549811·Cancer Epidemiol Biomarkers Prev·2009
8-other
Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
PMID 19454359·Hum Pathol·2009
8-other
Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
PMID 19414678·J Clin Oncol·2009
3-trial
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.
PMID 19156903·Cancer·2009
4-observational
Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta.
PMID 19299445·Mol Endocrinol·2009
8-other
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.
PMID 19202079·Proc Natl Acad Sci U S A·2009
8-other
Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome.
PMID 19179740·Indian Pediatr·2009
8-other
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
PMID 19156917·Cancer·2009
8-other
Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection.
PMID 19625411·J Virol·2009
8-other
Erythropoeisis-stimulating agents (ESAs) in cervix cancer: The "black box" paradox.
PMID 19127119·Cancer Biol Ther·2009
8-other
Novel therapeutics for patients with non-muscle-invasive bladder cancer.
PMID 19496717·Expert Rev Anticancer Ther·2009
6-review
Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
PMID 19031329·J Neurovirol·2009
8-other
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.
PMID 18848348·Urology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12303 DE PAUL DR
BRIDGETON, MO 63044 - Phone
- (314) 317-0600
Quick Facts
- NPI
- 1578729471
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile